SCHEMBL6717205

SCHEMBL6717205

O=C(Nc1ccc2c(c1)CNCC2)c1ccccc1F

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.70
RAB9A P51151 5/20 0.70
TP53 P04637 2/20 0.70
MAPT P10636 2/20 0.70
SMN1; SMN2 Q16637 2/20 0.70
NFKB1 P19838 1/20 0.70
HTT P42858 1/20 0.70
NFKB2 Q00653 1/20 0.70
RELA Q04206 1/20 0.70
MELK Q14680 1/20 0.66
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
TDP1 Q9NUW8 1/20 0.56
SLC2A1 P11166 1/20 0.55
ITGB3 P05106 3/20 0.53
ITGA2B P08514 2/20 0.53
ITGA2 P17301 2/20 0.53
LMNA P02545 1/20 0.52
HPGD P15428 1/20 0.52
PTPRC P08575 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4566270 0.82 MELK (0.76) NPC1RAB9ATP53SMN1; SMN2NFKB1
SCHEMBL29431209 0.82 MELK (0.76) NPC1RAB9ATP53SMN1; SMN2NFKB1
SCHEMBL7801349 0.80 MELK (0.54) NPC1RAB9ATP53MAPTSMN1; SMN2
SCHEMBL24892142 0.80 MELK (0.87) NPC1RAB9ATP53MAPTSMN1; SMN2
SCHEMBL31423364 0.78 MELK (0.55) MELKSLC2A1ITGB3ITGA2BITGA2
SCHEMBL7801352 0.78 MELK (0.52) NPC1RAB9ATP53MAPTSMN1; SMN2
SCHEMBL2804700 0.78 MEN1 (0.58) TP53HTTMELKMEN1KMT2A
SCHEMBL19279327 0.78 GRM5 (0.58) MELKSLC2A1ITGB3ITGA2BITGA2
Hydrochloric Acid SCHEMBL31423385 0.78 SLC2A1 (0.55) MELKSLC2A1ITGB3ITGA2BITGA2
SCHEMBL6643542 0.77 F2 (0.51) NPC1RAB9ATP53MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1183116-C Substituted isoquinoline derivatives, pharmaceutical composition containing same, preparation method and application thereof ʷ��˿�������ȳ�ķ���޹�˾ 2005-01-05 CN claimed
US-20040209912-A1 Substituted isoquinoline derivatives and their use as anticonvulsants SMITHKLINE BEECHAM P.L.C. 2004-10-21 US claimed
US-4022900-A Compositions containing 1,2,3,4-tetrahydroisoquinolines used as hypotensive agents MARION LABORATORIES, INC. (US) 1977-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040209912-A1 Substituted isoquinoline derivatives and their use as anticonvulsants INA, GRIN2C, GRIN2A NPC1 852/4885RAB9A 1671/4885TP53 4518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.